From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...

Licensing remains a dominant model. The value of the licensing-out deals signed by Chinese biotech firms in the first half of ...

Healthpeak Properties has written down the value of its Point Grand complex in South San Francisco by nearly $170 million.

Battelle has reacquired what's left of its bankrupt spinout and agreed to seed a fund to pay creditors pennies on the dollar.

Laboratory services provider Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a ...

The Government of Guyana yesterday officially commissioned its Biotechnology Plant Tissue Culture Laboratory at the National Agricultural Research and ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

Alexandria Real Estate Equities, Inc. faces ongoing headwinds, with soft biotech demand, and declining occupancy. Learn more ...

Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.